Category: Medosis Newsroom

In a significant milestone for Alzheimer’s treatment in Europe, the European Commission has granted approval to Leqembi (lecanemab), a groundbreaking…..

Contrary to fears that digital technology may harm cognitive health, a major new study has found that regular use of devices like smartphones and computers…..

Sanofi has released preliminary results from its Phase 2 TIDE-Asthma study evaluating Amlitelimab, an investigational monoclonal antibody, in adults with……

Pfizer has officially ceased development of its experimental oral weight-loss drug, Danuglipron, after a clinical trial participant experienced a suspected…..

A recent study published in JAMA Internal Medicine has raised concerns about the potential cancer risks associated with the widespread use of computed……